Product Information
ERYTHROMYCIN DR 250 MG TABLET is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $2.0848 per EA under NDC 52536018003. Its NADAC has been published 337 times since Sep 11, 2019.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536018003
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA062298FDA Approved
Before 1982
TE Code
AB
On Market Since
7/22/2019
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN DR 250 MG TABLET has been published 337 times since Sep 11, 2019, and over the history we have for it it has declined 70.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0848 per EA |
|---|---|
| All-time high | $7.0309 (Jul 15, 2020) |
| All-time low | $1.6915 (Feb 18, 2026) |
| 52-week high | $2.4837 |
| 52-week low | $1.6915 |
| Median price | $4.0918 |
| Average price | $4.0436 |
| Largest weekly change | +41.1% (Mar 22, 2023) |
| Weeks tracked | 337 |
| Tracking since | Sep 11, 2019 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN DR 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 250 MG TABLET, manufactured by Wilshire Pharmaceuticals Inc., is $2.0848 per EA (NDC 52536018003), effective Aug 19, 2026.
How has the price of ERYTHROMYCIN DR 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN DR 250 MG TABLET has declined 70.3%. It has been tracked across 337 weekly CMS publications since Sep 11, 2019.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 250 MG TABLET?
Since Sep 11, 2019, the NADAC for ERYTHROMYCIN DR 250 MG TABLET has ranged from a low of $1.6915 (Feb 18, 2026) to a high of $7.0309 (Jul 15, 2020), with a median of $4.0918 per EA.
Are there cheaper alternatives to ERYTHROMYCIN DR 250 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 250 MG TABLET, is $1.8831 per EA — about 10% below ERYTHROMYCIN DR 250 MG TABLET.
Who manufactures ERYTHROMYCIN DR 250 MG TABLET?
ERYTHROMYCIN DR 250 MG TABLET (NDC 52536018003) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.